Scientific trial startup ProofPilot scores $12M in Collection C funding

New York-based ProofPilot, a startup centered on scientific trials, introduced a $12 million Collection B funding spherical. Mitsui & Co. led the spherical, with participation from Sopris Capital, First Belief Capital Companions, Excelra and others. 

This new infusion of money brings the corporate’s whole funding spherical to roughly $15.7 million, according to Crunchbase


The corporate created a software-as-a-service analysis platform that it says can assist corporations and researchers run trials on “regulated and non-regulated services” with no need an inside infrastructure. Based in 2014, the corporate is targeted on serving to analysis establishments design research, interact sufferers and combine with apps or share outcomes. 

In 2020, the corporate teamed up with Massachusetts General Hospital (MGH) and Google Cloud to construct a brand new scientific analysis platform focused at educational medical facilities and universities. 


The corporate is trying to make use of the brand new funding {dollars} to develop its attain. 

“By our cost-effective and digitally-enabled platform, pharmaceutical and medical-device corporations can develop the efficacies of their present merchandise and discover the potential of digital well being options,” Matthew Amsden, CEO and cofounder of ProofPilot, mentioned in a press release.

“For the primary time, well being and wellness corporations can now entry scientific trials to substantiate their services at a manageable value. Furthermore, contributors can seamlessly interact in scientific trial help.”


Buyers are pouring a whole lot of tens of millions of {dollars} into the digital clinical-trial area. Medable, which focuses on digital decentralized scientific trials, scored $304 million in Collection D funding in October. 

However that is not the solely nine-figure deal within the area. TrialSpark, a health-tech platform that lets suppliers change into clinical-trial websites, scored $156 million in Collection C funding. Florence, which raked in $80 million in Collection C funding, and Lightship, which raised $40 million in funding, additionally work within the clinical-trial area.


Leave a Reply